Skip to main content
Log in

Health-related quality of life in patients with systemic lupus erythematosus: Development and validation of a lupus specific symptom checklist

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Reliable and sensitive measures are needed to evaluate the quality of life (QoL) in patients with systemic lupus erythematosus (SLE). No lupus specific questionnaires are available. This study describes the development and validation of a disease-specific questionnaire for lupus patients, which assesses the presence and burden of 38 disease- and treatment-related symptoms: the SLE Symptom Checklist (SSC). Reliability and reproducibility were tested in respectively 87 and 28 stable SLE patients. The internal consistency (Cronbach's α coefficients 0.89) and test–retest reliability (Pearson product–moment correlation coefficient between 0.67 and 0.87) were satisfactory. Concurrent validity was supported by significant, but moderate correlations with other measures of subjective well-being and functional status. Responsiveness was measured in 17 patients with lupus nephritis treated with cyclophosphamide, at start of therapy and 1 year thereafter. A significant change in number of symptoms and total distress level was found. It is concluded that the SSC has satisfactory psychometric properties and appears suitable for both clinical and research purposes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Liang MH, Rogers M, Larson M, et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984; 27: 13–19.

    Google Scholar 

  2. Joyce K, Berkebile C, Hastings C, Yarboro C. Health status and disease activity in systemic lupus erythematosus. Arthritis Care Res 1989; 2: 65–69.

    Google Scholar 

  3. Wekking EM, Vingerhoets AJ, van Dam AP, Nossent JC, Swaak AJ. Daily stressors and systemic lupus erythematosus: A longitudinal analysis-first findings. Psychother Psychosom 1991; 55: 108–113.

    Google Scholar 

  4. Wekking EM, Nossent JC, van Dam AP, Swaak AJ. Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother Psychosom 1991; 55: 126–131.

    Google Scholar 

  5. Dobkin PL, Fortin PR, Joseph L, et al. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res 1998; 11: 23–31.

    Google Scholar 

  6. Sutcliffe N, Clarke AE, Levinton C, et al. Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 1999; 26: 2352–2356.

    Google Scholar 

  7. Archenholtz B, Burckhardt CS, Segesten K. Quality of life of women with systemic lupus erythematosus or rheumatoid arthritis: Domains of importance and dissatisfaction. Qual Life Res 1999; 8: 411–416.

    Google Scholar 

  8. Swaak AJ, Nossent JC, Bronsveld W, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 447–454.

    Google Scholar 

  9. Boumpas DT, Fessler BJ, Austin HA III, et al. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995; 123: 42–53.

    Google Scholar 

  10. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337–1344.

    Google Scholar 

  11. Klippel JH. Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease (clinical conference). JAMA 1990; 263: 1812–1815.

    Google Scholar 

  12. Gladman DD. Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1996; 8: 430–437.

    Google Scholar 

  13. Burckhardt CS, Archenholtz B, Bjelle A. Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: A Swedish version of the Quality of Life Scale (QOLS). Scand J Rheumatol 1992; 21: 190–195.

    Google Scholar 

  14. Burckhardt CS, Archenholtz B, Bjelle A. Quality of life of women with systemic lupus erythematosus: A comparison with women with rheumatoid arthritis. J Rheumatol 1993; 20: 977–981.

    Google Scholar 

  15. Abu Shakra M, Mader R, Langevitz P, et al. Quality of life in systemic lupus erythematosus: A controlled study. J Rheumatol 1999; 26: 306–309.

    Google Scholar 

  16. Hanly JG. Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: Results of a cross-sectional study. Lupus 1997; 6: 243–247.

    Google Scholar 

  17. Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 309–313.

    Google Scholar 

  18. Rood MJ, Borggreve SE, Huizinga TWJ. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy. J Rheumatol 2000; 27: 2057–2059.

    Google Scholar 

  19. Thumboo J, Fong KY, Ng TP, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999; 26: 97–102.

    Google Scholar 

  20. Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1608–1614.

    Google Scholar 

  21. Gladman DD, Urowitz MB, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997; 24: 2145–2148.

    Google Scholar 

  22. Hochberg MC, Sutton JD. Physical disability and psychosocial dysfunction in systemic lupus erythematosus. J Rheumatol 1988; 15: 959–964.

    Google Scholar 

  23. Milligan SE, Hom DL, Ballou SP, et al. An assessment of the Health Assessment Questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 1993; 20: 972–976.

    Google Scholar 

  24. Krupp LB, LaRocca NG, Muir NJ, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.

    Google Scholar 

  25. Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999; 58: 379–381.

    Google Scholar 

  26. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996; 5: 190–195.

    Google Scholar 

  27. Laupacis A, Pus N, Muirhead N, et al. Disease-specific questionnaire for patients with a renal transplant. Nephron 1993; 64: 226–231.

    Google Scholar 

  28. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835–840.

    Google Scholar 

  29. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: A measure of symptom severity. Diabetic Med 1994; 11: 253–261.

    Google Scholar 

  30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640.

    Google Scholar 

  31. Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. De ontwikkeling van de IRGL. Een instrument om gezondheid te meten bij pati Ënten met reuma/Development of a Dutch health status measure for patients with arthritis. Gedrag en Gezondheid 1990; 18: 78–89.

    Google Scholar 

  32. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum 1980; 23: 146–152.

    Google Scholar 

  33. Wald FD, Mellenbergh GJ. De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS)/The shortenedversion of the Dutch translation of the Profile of Mood States (POMS). Nederlands Tijdschrift voor de Psychologie en haar Grensgebieden 1990; 45: 86–90.

    Google Scholar 

  34. Groot de MH. Psychometrische aspecten van een stemmingsschaal (Verkorte POMS) /Psychometric characteristics of a moodstates inventory: ShortenedPOMS. Gedrag en Gezondheid 1992; 20: 46–51.

    Google Scholar 

  35. Reddon JR, Marceau R, Holden RR. A confirmatory evaluation of the Profile of Mood States: convergent and discriminant item validity. J Psychopathol Behavioral Assess 1985; 7: 243–259.

    Google Scholar 

  36. Aaronson NK, Acquadro C, Alonso J, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992; 1: 349–351.

    Google Scholar 

  37. Ware JE. SF-36 Health Survey. Manual and Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Center, 1993.

    Google Scholar 

  38. Zee van der K, Sanderman R, Heyink J. De psychometrische kwaliteiten van de MOS 36-item Short Form Health Survey (SF-36) in een Nederlandse populatie/The psychometric qualities of the MOS 36-item Short Form Health Survey (SF-36) in a Dutch population. T Soc Gezondheidsz 1993; 71: 183–191.

    Google Scholar 

  39. Pouchot J, De Bandt M, Guillevin L, et al. Psychometric properties of the SF-36 and the AIMS2-SF in patients with systemic lupus erythematosus (SLE). Qual Life Res 1999; 8: A153.

    Google Scholar 

  40. Gladman D, Urowitz M, Fortin P, et al. Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 1996; 23: 1953–1955.

    Google Scholar 

  41. StrandV, Gladman D, Isenberg D, et al. Outcome measures to be usedin clinical trials in systemic lupus erythematosus. J Rheumatol 1999; 26: 490–497.

    Google Scholar 

  42. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

    Google Scholar 

  43. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334.

    Google Scholar 

  44. Snoek FJ. Quality of life: a closer look at measuring patients' well-being. Diabetes Spectrum 2000; 13: 24–28.

    Google Scholar 

  45. Krupp LB, LaRocca NG, Muir J, Steinberg AD. A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990; 17: 1450–1452.

    Google Scholar 

  46. Wysenbeek AJ, Leibovici L, Weinberger A, Guedj D. Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol 1993; 32: 633–635.

    Google Scholar 

  47. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol 1998; 25: 892–895.

    Google Scholar 

  48. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998; 7: 101–107.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grootscholten, C., Ligtenberg, G., Derksen, R. et al. Health-related quality of life in patients with systemic lupus erythematosus: Development and validation of a lupus specific symptom checklist. Qual Life Res 12, 635–644 (2003). https://doi.org/10.1023/A:1025176407776

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025176407776

Navigation